Showing results (361-370 of 390) with videos related to

Sort By:
Pageof 39
The Journal of Clinical Investigation|March 11, 2009
Ca2+/calmodulin-dependent kinase II triggers cell membrane injury by inducing complement factor B gene expression in the mouse heartMadhu V Singh, Ann Kapoun, Linda Higgins, et al.
The Journal of Emergency Medicine|January 14, 2023
Impact of Race and Ethnicity on Emergency Medical Services Administration of Opioid Pain Medications for Injured ChildrenDaniel K Nishijima, Daniel J Tancredi, Kathleen M Adelgais, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 2020
Olaparib Versus Nonplatinum Chemotherapy in Patients With Platinum-Sensitive Relapsed Ovarian Cancer and a Germline BRCA1/2 Mutation (SOLO3): A Randomized Phase III TrialRichard T Penson, Ricardo Villalobos Valencia, David Cibula, et al.
Pediatric Emergency Care|May 22, 2025
Racial and Ethnic Differences in ED Analgesia Among Injured Children Transported Via EMSSarahjean Kerolle, Lorin R Browne, Ruta Brazauskas, et al.
Gynecologic Oncology|November 13, 2024
Adverse events in the placebo arm of SOLO2/ENGOT-Ov21 maintenance trial of olaparib in recurrent ovarian cancerKatherine Elizabeth Francis, Sandy Simon, Val Gebski, et al.
Circulation|August 10, 2011
Striking In vivo phenotype of a disease-associated human SCN5A mutation producing minimal changes in vitroHiroshi Watanabe, Tao Yang, Dina Myers Stroud, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 12, 2024
Olaparib as Treatment Versus Nonplatinum Chemotherapy in Patients With Platinum-Sensitive Relapsed Ovarian Cancer: Phase III SOLO3 Study Final Overall Survival ResultsGiovanni Scambia, Ricardo Villalobos Valencia, Nicoletta Colombo, et al.
Pageof 39